{"id":"https://openalex.org/W88707344","doi":null,"title":"Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.","display_name":"Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.","publication_year":2005,"publication_date":"2005-01-01","ids":{"openalex":"https://openalex.org/W88707344","mag":"88707344","pmid":"https://pubmed.ncbi.nlm.nih.gov/17319106","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1993948"},"language":"en","primary_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1993948","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1993948/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1993948/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vasc Health Risk Manag","raw_type":"Text"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1993948/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053734867","display_name":"Michio Otsuki","orcid":"https://orcid.org/0000-0001-5947-8621","observed_orcids":["https://orcid.org/0000-0001-5947-8621"]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michio Otsuki","raw_affiliation_strings":["Department of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan","institution_ids":["https://openalex.org/I98285908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103631989","display_name":"Kayoko Goya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kayoko Goya","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5013604895","display_name":"Soji Kasayama","orcid":"https://orcid.org/0000-0001-7380-6169","observed_orcids":["https://orcid.org/0000-0001-7380-6169"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soji Kasayama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3916,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.60246076,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"1","issue":"3","first_page":"209","last_page":"15"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.7865999937057495,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.155799999833107,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.01889999955892563,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9200000166893005},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/vascular-endothelium","display_name":"vascular endothelium","score":0.9279999732971191},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9079999923706055},{"id":"https://openalex.org/keywords/beraprost-sodium","display_name":"beraprost sodium","score":0.9980000257492065},{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/prostaglandin-i2-analogue","display_name":"prostaglandin I2 analogue","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pparalpha","display_name":"PPAR\u03b1","score":0.9589999914169312},{"id":"https://openalex.org/keywords/vcam-1","display_name":"VCAM-1","score":0.9679999947547913},{"id":"https://openalex.org/keywords/endothelial-nitric-oxide-synthase","display_name":"endothelial nitric oxide synthase","score":0.9819999933242798},{"id":"https://openalex.org/keywords/carotid-atherosclerosis","display_name":"carotid atherosclerosis","score":0.8960000276565552},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.9829999804496765},{"id":"https://openalex.org/keywords/endothelium-dependent-vasodilatation","display_name":"endothelium-dependent vasodilatation","score":0.8659999966621399},{"id":"https://openalex.org/keywords/antiatherosclerotic-therapy","display_name":"antiatherosclerotic therapy","score":0.9330000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9094396829605103},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.7163362503051758},{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.6845865845680237},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.684057354927063},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6831396222114563},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.6317358613014221},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.6007024645805359},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.523609459400177},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.4841178357601166},{"id":"https://openalex.org/C2777660278","wikidata":"https://www.wikidata.org/wiki/Q489997","display_name":"Diabetic angiopathy","level":3,"score":0.4350389838218689},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4237176477909088}],"mesh":[{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003925","descriptor_name":"Diabetic Angiopathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011345","descriptor_name":"Fenofibrate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011464","descriptor_name":"Epoprostenol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014664","descriptor_name":"Vasodilation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014665","descriptor_name":"Vasodilator Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019010","descriptor_name":"Vascular Cell Adhesion Molecule-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D052250","descriptor_name":"Nitric Oxide Synthase Type III","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"pmh:oai:pubmedcentral.nih.gov:1993948","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1993948/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1993948/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vasc Health Risk Manag","raw_type":"Text"},{"id":"pmid:17319106","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17319106","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vascular health and risk management","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:be4c7555398643f0b7addc3123ed48a2","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/be4c7555398643f0b7addc3123ed48a2","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vascular Health and Risk Management, Vol Volume 1, Pp 209-215 (2005)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1993948","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1993948/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1993948/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vasc Health Risk Manag","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W88707344.pdf","grobid_xml":"https://content.openalex.org/works/W88707344.grobid-xml"},"referenced_works_count":61,"referenced_works":["https://openalex.org/W1502524639","https://openalex.org/W1521959273","https://openalex.org/W1545732697","https://openalex.org/W1965148671","https://openalex.org/W1971175832","https://openalex.org/W1981706000","https://openalex.org/W1986579939","https://openalex.org/W1988781735","https://openalex.org/W1990800912","https://openalex.org/W1993145269","https://openalex.org/W1993387626","https://openalex.org/W1999233620","https://openalex.org/W2001751639","https://openalex.org/W2003120746","https://openalex.org/W2003382978","https://openalex.org/W2009179022","https://openalex.org/W2014759828","https://openalex.org/W2017604478","https://openalex.org/W2022879391","https://openalex.org/W2026266301","https://openalex.org/W2028695980","https://openalex.org/W2029749250","https://openalex.org/W2031185570","https://openalex.org/W2036427107","https://openalex.org/W2038273086","https://openalex.org/W2042518766","https://openalex.org/W2043421666","https://openalex.org/W2043595406","https://openalex.org/W2044634951","https://openalex.org/W2046809996","https://openalex.org/W2050904588","https://openalex.org/W2057651652","https://openalex.org/W2069544196","https://openalex.org/W2082680963","https://openalex.org/W2083217753","https://openalex.org/W2088105814","https://openalex.org/W2088948618","https://openalex.org/W2091181219","https://openalex.org/W2095070268","https://openalex.org/W2097103756","https://openalex.org/W2097131595","https://openalex.org/W2100926526","https://openalex.org/W2102267426","https://openalex.org/W2106900101","https://openalex.org/W2107295258","https://openalex.org/W2110733021","https://openalex.org/W2111076682","https://openalex.org/W2116544253","https://openalex.org/W2120781242","https://openalex.org/W2123560318","https://openalex.org/W2135978289","https://openalex.org/W2137408480","https://openalex.org/W2139634859","https://openalex.org/W2140424939","https://openalex.org/W2161672871","https://openalex.org/W2162278141","https://openalex.org/W2302447233","https://openalex.org/W2324841714","https://openalex.org/W2341645956","https://openalex.org/W2565726191","https://openalex.org/W2769264260"],"related_works":["https://openalex.org/W2036427107","https://openalex.org/W1988781735","https://openalex.org/W3031114783","https://openalex.org/W1892798305","https://openalex.org/W2035626780","https://openalex.org/W2160735160","https://openalex.org/W1540013615","https://openalex.org/W2288359990","https://openalex.org/W2135256192","https://openalex.org/W2060201681"],"abstract_inverted_index":{"Diabetes":[0],"mellitus":[1,18,28],"is":[2,58],"an":[3],"important":[4,192],"risk":[5],"factor":[6],"for":[7,111,193],"cardiovascular":[8],"morbidity":[9],"and":[10,74,103,114,136,172],"mortality.":[11],"The":[12,180],"metabolic":[13],"abnormalities":[14],"caused":[15],"by":[16],"diabetes":[17,27,85,123,200],"induce":[19],"vascular":[20,91,129,154,188],"endothelial":[21,158],"dysfunction":[22],"that":[23,36],"predisposes":[24],"patients":[25,81,119],"with":[26,82,120],"to":[29,61,77,168,173,182],"atherosclerosis.":[30,179],"Two":[31],"mega":[32],"clinical":[33],"trials":[34],"showed":[35],"intensive":[37],"glycemic":[38],"control":[39],"does":[40],"not":[41],"have":[42],"favorable":[43],"effects":[44,65,167],"on":[45,69,90],"reducing":[46],"macrovascular":[47],"events":[48],"although":[49],"it":[50],"demonstrated":[51],"significant":[52],"reductions":[53],"in":[54,80,118,143,153,187,197],"microvascular":[55],"complications.":[56],"It":[57],"becoming":[59],"worthwhile":[60],"clarify":[62],"the":[63,97,104,112,138,175,184,195],"beneficial":[64],"of":[66,96,116,140,177],"tight":[67],"controls":[68],"blood":[70],"pressure,":[71],"serum":[72],"lipids,":[73],"postprandial":[75],"hyperglycemia":[76],"prevent":[78,174],"atherosclerosis":[79,117,142,196],"type":[83,121,144,198],"2":[84,122,145,199],"mellitus.":[86,124,201],"Here,":[87],"we":[88],"focus":[89],"endothelium":[92,189],"as":[93],"a":[94],"target":[95,183],"prostaglandin":[98],"I2":[99],"analog":[100],"beraprost":[101],"sodium":[102,126],"peroxisome":[105],"proliferators-activated":[106],"receptor":[107],"alpha":[108],"activator":[109],"fenofibrate":[110],"prevention":[113],"treatment":[115],"Beraprost":[125],"lowered":[127],"circulating":[128],"cell":[130],"adhesion":[131],"molecule-":[132],"1":[133],"(VCAM-1)":[134],"concentration":[135],"prevented":[137],"progression":[139,176],"carotid":[141],"diabetic":[146],"patients,":[147],"probably":[148],"through":[149],"inhibiting":[150],"VCAM-1":[151],"expression":[152],"endothelium.":[155],"Fenofibrate":[156],"up-regulated":[157],"nitric":[159],"oxide":[160],"synthase":[161],"expression,":[162],"which":[163],"may":[164],"explain":[165],"its":[166],"improve":[169],"endothelium-dependent":[170],"vasodilatation":[171],"coronary":[178],"approaches":[181],"molecules":[185],"expressed":[186],"will":[190],"become":[191],"preventing":[194]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2016-06-24T00:00:00"}